论文部分内容阅读
目的:比较射干麻黄汤化裁联合舒利迭与单用舒利迭治疗支气管哮喘的有效性。方法:将140例支气管哮喘(中医辨证为冷哮证,下同。)患者随机分成两组,分别使用射干麻黄汤化裁联合舒利迭(即治疗组)与单用舒利迭(即对照组)治疗8周,在治疗前后观察肺功能和临床症状、体征的改变。结果:两组患者在治疗8周后,肺功能均较治疗前有明显改善(P<0.05);治疗8周后,治疗组FVC、FEV1和PEFR改善均优于对照组(P<0.05);治疗组的临床症状评分明显优于对照组(P<0.05);治疗组的不良反应发生率明显低于对照组。结论:射干麻黄汤化裁联合舒利迭治疗哮喘(冷哮证)能更好地改善临床症状和肺功能,且可降低舒利迭的不良反应发生率。
Objective: To compare the efficacy of Shegan Mahuang Decoction combined with seretide alone and seretide for the treatment of bronchial asthma. Methods: One hundred and forty cases of bronchial asthma (syndrome differentiation of cold syndrome, the same below) were randomly divided into two groups. The patients were treated with Shegan Mahuang Decoction combined with seretide (namely, treatment group) and with seretide alone Group) for 8 weeks, observed before and after treatment of lung function and clinical symptoms and signs of change. Results: After 8 weeks of treatment, the lung function of both groups improved significantly (P <0.05). After 8 weeks of treatment, the improvements of FVC, FEV1 and PEFR in the treatment group were better than those in the control group (P <0.05). The scores of clinical symptoms in the treatment group were significantly better than those in the control group (P <0.05). The incidence of adverse reactions in the treatment group was significantly lower than that in the control group. Conclusion: Shegan Mahuang Decoction combined with seretide treatment of asthma (cold syndrome) can better improve clinical symptoms and lung function, and reduce the incidence of adverse effects of Seretide.